BANNER
Banner Life Sciences Llc
Application Filed: 2003-06-17
Trademark Application Details
REGISTERED AND RENEWED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78263135 |
| Registration Number | 2962023 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | L30 |
| Employee Name | STIGLITZ, SUSAN R |
Timeline
| 2003-06-17 | Application Filed |
| 2005-03-22 | Published for Opposition |
| 2005-06-14 | Trademark Registered |
| 2015-06-13 | Location: GENERIC WEB UPDATE |
| 2015-06-13 | Status: Live/Registered |
| 2015-06-14 | Renewal Date |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BANNER LIFE SCIENCES LLC |
| Address | 4125 PREMIER DRIVE HIGH POINT DE 27265 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 020133 | Grotesque men formed by letters, numbers, punctuation or geometric shapes; Stick figures |
| 040703 | Geometric figures or combinations of geometric figures representing a person; Geometric figures representing a person; Geometric shapes forming a person; Person formed by geometric shapes |
| 260302 | Ovals, plain single line; Plain single line ovals |
| 260314 | Ovals, three or more; Three or more ovals |
| 260321 | Ovals that are completely or partially shaded |
| 260502 | Plain single line triangles; Triangles, plain single line |
| 260525 | Triangles with one or more curved sides |
| 270301 | Geometric figures forming letters, numerals or punctuation |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Soft gelatin and non-animal film encapsulations and hard core enrobements of various pharmaceutical products, namely, [ AIDS related complex (ARC) therapeutic agents; ] antidiarrheals; antihistamines; analgesics; [ antacids; ] antiflatulents; [ antifungals; ] antiemetics; antipyretics; antiarthritics; [ antiinfectives for the treatment of fungal and viral infections; ] antinauseants; [ antiobesity; blood growth factor products; cancer therapy products; calcium supplements; cardiovascular agents, namely, calcium channel blockers for heart disease; ] cough and cold preparations; [ digestants; diuretics; dermatologicals for the treatment of skin disorders; ] gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; [ hormones; ] histamine H2 receptor antagonists; hypnotics; hypolipidemics; laxatives; musculoskeletal products, namely, [ calcium, ] vitamin D and osteoporosis treatments; psychotherapeutics; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of neurological disorders; drugs for the treatment of respiratory disorders; sedatives; [ drugs for the treatment of seizure disorders; ] sleep aids; [ drugs for the treatment of sexual dysfunction; ] transplant and immunosuppressant products, namely, cyclosporine; [ pharmaceutical preparations for the treatment of vascular disorders; ] soft gelatin and non-animal film encapsulations and hard core enrobements of natural medicine products, namely, [ a full line of ] herbal supplements; vitamin and mineral supplements and nutritional supplements, namely, [ a full line of ] vitamin and mineral supplements, nutritional supplements and herbal products; Pharmaceutical preparations, namely, [ AIDS related complex (ARC) therapeutic agents; ] antidiarrheals; antihistamines; analgesics; [ antacids; ] antiflatulents; [ antifungals; ] antiemetics; antipyretics; antiarthritics; [ antiinfectives for the treatment of fungal and viral infections; ] antinauseants; [ antiobesity; blood growth factor products; cancer therapy products; calcium supplements; cardiovascular agents, namely, calcium channel blockers for heart disease; ] cough and cold preparations; [ digestants; diuretics; dermatologicals for the treatment of skin disorders; ] gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; [ hormones; ] histamine H2 receptor antagonists; hypnotics; hypolipidemics; laxatives; musculoskeletal products, namely, [ calcium, ] vitamin D and osteoporosis treatments; psychotherapeutics; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of neurological disorders; drugs for the treatment of respiratory disorders; sedatives; drugs for the treatment of seizure disorders; sleep aids; [ drugs for the treatment of sexual dysfunction; ] transplant and immunosuppressant products, namely, cyclosporine; [ pharmaceutical preparations for the treatment of vascular disorders; ] soft gelatin and non-animal film encapsulations and hard core enrobements of natural medicine products, namely, [ a full line of ] herbal supplements; vitamin and mineral supplements and nutritional supplements, namely, [ a full line of ] vitamin and mineral supplements, nutritional supplements and herbal products |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2003-11-25 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION E-MAILED | 2003-11-25 | 2 GNRT F:First Action |
| PAPER RECEIVED | 2004-05-26 | 3 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-05-25 | 4 CRFA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-05-25 | 5 CRFA I:Incoming Correspondence |
| LETTER OF SUSPENSION E-MAILED | 2004-06-25 | 6 GNSL S: |
| PAPER RECEIVED | 2004-08-04 | 7 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-08-04 | 8 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2004-08-12 | 9 ACEC I:Incoming Correspondence |
| Sec. 1(B) CLAIM DELETED | 2004-08-24 | 10 1.BD I:Incoming Correspondence |
| EXAMINERS AMENDMENT E-MAILED | 2004-08-25 | 11 GNEA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2004-08-25 | 12 ALIE A:Allowance for Publication |
| EXAMINER'S AMENDMENT ENTERED | 2004-08-25 | 13 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2004-08-27 | 14 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2004-09-17 | 15 PREV O:Outgoing Correspondence |
| CASE FILE IN TICRS | 2004-09-29 | 16 CFIT O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-03-02 | 17 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-03-22 | 18 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2005-06-14 | 19 R.PR A:Allowance for Publication |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2006-05-17 | 20 ASGN I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-07-11 | 21 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-07-11 | 22 TCCA I:Incoming Correspondence |
| TEAS SECTION 8 & 15 RECEIVED | 2011-01-21 | 23 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2011-02-03 | 24 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2011-02-03 | 25 C15A O:Outgoing Correspondence |
| TEAS SECTION 7 REQUEST RECEIVED | 2011-07-06 | 26 ES7R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2011-07-13 | 27 APRE A:Allowance for Publication |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2011-07-21 | 28 APRE A:Allowance for Publication |
| REGISTERED - SEC. 7 REQUEST ABANDONED | 2011-07-25 | 29 PRA7 O:Outgoing Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2012-12-26 | 30 ASCK I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2014-04-30 | 31 ASCK I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2014-12-24 | 32 ASGN I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2014-12-31 | 33 TCCA I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2015-05-26 | 34 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2015-06-13 | 35 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2015-06-13 | 36 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2015-06-13 | 37 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2015-06-13 | 38 NA89 E:E-Mail |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2015-08-05 | 39 ASCK I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2024-06-14 | 40 REM2 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 